-
-
-
-
B647972-10mgBMS-587101 is a potent and orally active antagonist of leukocyte function associated antigen-1 (LFA-1). BMS-587101 has anti-inflammatory effects and can be used for rheumatoid arthritis research.In VitroBMS-587101 is a moderately potent inhibitor of
-
B647972-5mgBMS-587101 is a potent and orally active antagonist of leukocyte function associated antigen-1 (LFA-1). BMS-587101 has anti-inflammatory effects and can be used for rheumatoid arthritis research.In VitroBMS-587101 is a moderately potent inhibitor of
-
B655243-1mlBMS-587101 is a potent and orally active antagonist of leukocyte function associated antigen-1 (LFA-1). BMS-587101 has anti-inflammatory effects and can be used for rheumatoid arthritis research.In VitroBMS-587101 is a moderately potent inhibitor of
-
C658753-10mgc(phg-isoDGR-(NMe)k) TFA is a selective and potent α5β1-integrin ligand with an IC 50 of 2.9 nM.Appearance:SolidIC50& Target:IC50: 2.9 nM (α5β1)In Vivo:c(phg-isoDGR-(NMe)k) TFA is trimerized with the chelator TRAP and used as a positron-emission
-
C658753-1mgc(phg-isoDGR-(NMe)k) TFA is a selective and potent α5β1-integrin ligand with an IC 50 of 2.9 nM.Appearance:SolidIC50& Target:IC50: 2.9 nM (α5β1)In Vivo:c(phg-isoDGR-(NMe)k) TFA is trimerized with the chelator TRAP and used as a positron-emission
-
C658753-5mgc(phg-isoDGR-(NMe)k) TFA is a selective and potent α5β1-integrin ligand with an IC 50 of 2.9 nM.Appearance:SolidIC50& Target:IC50: 2.9 nM (α5β1)In Vivo:c(phg-isoDGR-(NMe)k) TFA is trimerized with the chelator TRAP and used as a positron-emission
-
C648902-10mgCertepetide (CEND-1) is a bifunctional cyclic peptide (a.k.a. iRGD). Certepetide is a tumor-penetrating enhancer via RGD motif interaction with alphav-integrins and via activating NRP-1 , and transforms the solid tumor microenvironment into a
-
C648902-1mgCertepetide (CEND-1) is a bifunctional cyclic peptide (a.k.a. iRGD). Certepetide is a tumor-penetrating enhancer via RGD motif interaction with alphav-integrins and via activating NRP-1 , and transforms the solid tumor microenvironment into a
-
C648902-5mgCertepetide (CEND-1) is a bifunctional cyclic peptide (a.k.a. iRGD). Certepetide is a tumor-penetrating enhancer via RGD motif interaction with alphav-integrins and via activating NRP-1 , and transforms the solid tumor microenvironment into a